EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies.
about
EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas.Epstein-Barr Virus-Associated Gastric Carcinoma and Specific Features of the Accompanying Immune ResponseThe criteria to confirm the role of Epstein-Barr virus in nasopharyngeal carcinoma initiationEffusanin E suppresses nasopharyngeal carcinoma cell growth by inhibiting NF-κB and COX-2 signalingEpstein-Barr virus-encoded latent membrane protein 1 impairs G2 checkpoint in human nasopharyngeal epithelial cells through defective Chk1 activationL-DOPA decarboxylase mRNA expression is associated with tumor stage and size in head and neck squamous cell carcinoma: a retrospective cohort study.Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9Genetic polymorphisms of TLR3 are associated with Nasopharyngeal carcinoma risk in Cantonese population.SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma.Anti-tumor effect of oncolytic herpes simplex virus G47delta on human nasopharyngeal carcinoma.Poly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells.Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinomaIdentification of a novel methylated gene in nasopharyngeal carcinoma: TTC40Viral latency and its regulation: lessons from the gamma-herpesviruses.In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient.Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells.Quantitative expression analysis and prognostic significance of the BCL2-associated X gene in nasopharyngeal carcinoma: a retrospective cohort study.Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technologyA pooled analysis of the IL-10-1082 A/G polymorphism and the nasopharyngeal carcinoma susceptibility.Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.Characterization of the Variability of Epstein-Barr Virus Genes in Nasopharyngeal Biopsies: Potential Predictors for Carcinoma ProgressionEpstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral ReplicationDried-blood sampling for epstein-barr virus immunoglobulin G (IgG) and IgA serology in nasopharyngeal carcinoma screening.Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma.Anticancer effects of 3,3'-diindolylmethane are associated with G1 arrest and mitochondria-dependent apoptosis in human nasopharyngeal carcinoma cellsTransient overexpression of TGFBR3 induces apoptosis in human nasopharyngeal carcinoma CNE-2Z cells.Recurrent overexpression of c-IAP2 in EBV-associated nasopharyngeal carcinomas: critical role in resistance to Toll-like receptor 3-mediated apoptosisGenetic polymorphisms in host innate immune sensor genes and the risk of nasopharyngeal carcinoma in North Africa.Suppressing tumor growth of nasopharyngeal carcinoma by hTERTC27 polypeptide delivered through adeno-associated virus plus adenovirus vector cocktail.Tumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinomaCannabis, tobacco and domestic fumes intake are associated with nasopharyngeal carcinoma in North Africa.Triptolide Combined with Radiotherapy for the Treatment of Nasopharyngeal Carcinoma via NF-κB-Related Mechanism.Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinomaAlternative endpoints to the 5-year overall survival and locoregional control for nasopharyngeal carcinoma: A retrospective analysis of 2,450 patientsComprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing.The full-length DNA sequence of Epstein Barr virus from a human gastric carcinoma cell line, SNU-719.Quantitative measurement of iNOS expression in melanoma, nasopharyngeal, colorectal, and breast tumors of Tunisian patients: comparative study and clinical significance.Epigenetic alteration of the Wnt inhibitory factor-1 promoter is common and occurs in advanced stage of Tunisian nasopharyngeal carcinoma.XRCC1 and hOGG1 genes and risk of nasopharyngeal carcinoma in North African countries.
P2860
Q24804219-6511AED3-FB07-4A86-B1C5-8537E8C3C5BAQ26751029-64DAF448-2D86-4923-A5F7-CE3B370C7B31Q26853527-94B9027D-C2BC-4C7A-8006-7E5B92E5977AQ28543963-94600BBD-3384-45B6-88FB-A3032D0D8C64Q28728022-5A5C5374-3D80-4FC4-A19A-692BA882C514Q31105430-01ACFAE3-75F1-455D-A2F8-4FE5D25E2A01Q33265945-5D72FE02-FB6A-4FBF-896C-7E40A59F213AQ33302872-334F3F7C-8701-4D47-B9E8-694AA38622F2Q33470022-E1331A9C-F2B7-4547-BB49-BDED1F5B179EQ33579396-92E65736-53C3-499F-9030-419D3A2140C6Q33615280-3F2C9B77-5FD2-4BA8-8BA5-F97EF474ADA8Q33818584-E34A1EA5-4AF9-4F14-9994-F66512B2E75AQ33912110-A4AB7D00-3353-4607-B439-141919630803Q34039189-C167A1E3-4853-43A0-B886-3DB43BF42787Q34092709-085EEF36-7FA5-4E3E-A49E-0C881314BC7DQ34228526-E0D3BCAF-C482-4F86-BCFA-BF374E64902FQ34282719-DC2DF84A-F761-4878-97D7-9262E41B8E59Q34777413-4C97D97C-51CB-4FF9-AEC3-86FD5A6B7B37Q35363383-09350E58-0CCE-4EA1-889D-3C322E312F67Q35535344-6F483F41-3F40-4514-A36B-B46BAF4E6938Q35769567-B235A4F6-6296-4E81-8135-A767A3863F3AQ35987387-F0696411-7F8F-4E0A-B439-7DD084BB6124Q36434290-BA5A0C21-ECE5-4140-96FA-49058C161F50Q36539838-5C31C420-9B27-4EA0-A5EC-433C017F5C63Q36611031-F1F55E21-0C72-4AC5-97CF-B997FAB1FF34Q36611614-D51C3014-04AB-4975-B757-671406045604Q36680150-315035E8-5B8E-4AA4-AF0F-507B2EDE87DBQ36944175-7EB2FABA-FED1-48E2-B729-115CDC57E2ADQ36947272-80BDB4CE-AF43-4271-A9A0-5E193457B822Q37183614-BCFFDE52-C0F9-45CC-9547-F71324DE381CQ37183789-5BE7F7E6-93BA-48FB-BBD2-F298AE994789Q37400588-44ADAFD5-1AF8-4561-812E-CFB3644DD452Q37534942-710FA984-8F94-46F0-B8BF-E8887EA72AC2Q37548853-49331DAC-54FC-42A8-A67F-D6123915E6B5Q37722215-8CE492BC-2550-4DAE-8098-C3A298CC45AEQ38786932-96C4C7EF-0A36-43A4-9F60-617F491340DAQ38828516-CE416A7E-CF14-475D-9FB1-4727882C63F3Q38959951-C3F591EA-D332-44F0-B625-A3DB601BEDE2Q39001870-956D2899-51AC-4958-AC4B-6E2D0311AD92Q39155231-F5BCE3DA-FF84-44BF-93D1-6BC1CA2E8A02
P2860
EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
EBV-associated nasopharyngeal ...... to virus-targeting strategies.
@ast
EBV-associated nasopharyngeal ...... to virus-targeting strategies.
@en
type
label
EBV-associated nasopharyngeal ...... to virus-targeting strategies.
@ast
EBV-associated nasopharyngeal ...... to virus-targeting strategies.
@en
prefLabel
EBV-associated nasopharyngeal ...... to virus-targeting strategies.
@ast
EBV-associated nasopharyngeal ...... to virus-targeting strategies.
@en
P2093
P1476
EBV-associated nasopharyngeal ...... to virus-targeting strategies.
@en
P2093
Cécile Keryer
Marilys Corbex
Pierre Busson
Tadamassa Ooka
P304
P356
10.1016/J.TIM.2004.06.005
P577
2004-08-01T00:00:00Z